Evidence map›Paper›PMID 42218328›Full record

ArticleScientific reports2026

Silicone elastomer films loaded with 5-fluorouracil for time-dependent drug release.

Mari Atabekyan, Zoya Farmazyan, Nelly Avagyan, Vigen Topuzyan, Nelly Babayan, Kristine Harutyunyan, Natalya Sarkisyan, Ruzanna Grigoryan, Stepan Grigoryan

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mari AtabekyanScientific and Technological Centre of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia, A.L. Mnjoyan Institute of Fine Organic Chemistry, 26 Azatutyan Ave, 0014, Yerevan, Armenia.
Zoya FarmazyanScientific and Technological Centre of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia, A.L. Mnjoyan Institute of Fine Organic Chemistry, 26 Azatutyan Ave, 0014, Yerevan, Armenia.
Nelly AvagyanScientific and Technological Centre of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia, A.L. Mnjoyan Institute of Fine Organic Chemistry, 26 Azatutyan Ave, 0014, Yerevan, Armenia.
Vigen TopuzyanScientific and Technological Centre of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia, A.L. Mnjoyan Institute of Fine Organic Chemistry, 26 Azatutyan Ave, 0014, Yerevan, Armenia.
Nelly BabayanInstitute of Molecular Biology of the National Academy of Sciences of the Republic of Armenia, 7 Ezras Hasratyan St, 0014, Yerevan, Armenia.
Kristine HarutyunyanInstitute of Molecular Biology of the National Academy of Sciences of the Republic of Armenia, 7 Ezras Hasratyan St, 0014, Yerevan, Armenia.
Natalya SarkisyanInstitute of Molecular Biology of the National Academy of Sciences of the Republic of Armenia, 7 Ezras Hasratyan St, 0014, Yerevan, Armenia.
Ruzanna GrigoryanInstitute of Molecular Biology of the National Academy of Sciences of the Republic of Armenia, 7 Ezras Hasratyan St, 0014, Yerevan, Armenia.
Stepan GrigoryanScientific and Technological Centre of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia, A.L. Mnjoyan Institute of Fine Organic Chemistry, 26 Azatutyan Ave, 0014, Yerevan, Armenia. sgrig@sci.am.

Funding

Higher Education and Science Committee of the Republic of Armenia Science Program: "Study of methods of synthesis and properties (chemical, physicochemical, pharmacological, etc.) of new organic compounds. Creation of new materials with applied purpose".
6 · The paper itself

Abstract

Silicone elastomer composite films loaded with the antitumor drug 5-fluorouracil (5-FU) were developed for controlled release applications. Polydimethylsiloxane (PDMSOH) films were crosslinked using tetraethoxysilane and room-temperature vulcanization catalysts, with glycerol incorporated as a hydrophilic modifier to regulate permeability of the hydrophobic silicone matrix. Dimethyl sulfoxide was used to solubilize 5-FU during film preparation. Film microstructure and drug distribution were analyzed by scanning electron microscopy and Raman spectroscopic imaging. Among the tested formulations, the film containing 30 wt.% glycerol (F-4) exhibited uniform drug distribution and the most favorable 5-FU release profile in 0.9% NaCl solution, consistent with its morphological characteristics. Cytotoxicity and cytocompatibility were assessed in A549 and HepG2 cells using an ISO 10993-5 extract test. Extracts from the blank F-4 film were minimal cytotoxic across all extraction times, whereas extracts from the 5-FU-loaded F-4 film produced a time-dependent reduction in cell viability in both cell lines. The extract-mediated cytotoxicity closely followed the UV-Vis release profile, indicating that the biological response was predominantly driven by time-dependent 5-FU release rather than film-derived leachables. Overall, glycerol-modified PDMSOH films provide a tunable platform for sustained 5-FU delivery.

Indexed as

Drug LiberationFluorouracilSilicone ElastomersA549 CellsCell SurvivalDelayed-Action PreparationsDimethylpolysiloxanesGlycerolHep G2 CellsHumansDelayed-Action PreparationsDimethylpolysiloxanesFluorouracilGlycerolSilicone Elastomers5-Fluorouracil5-FU release rateComposite silicone filmsCytotoxicityGlycerolMicrostructure

Identifiers

PMID42218328
PMCPMC13454293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.